Insights

Innovative Treatment Portfolio Pulmonx's flagship Zephyr Endobronchial Valve represents a minimally invasive solution for severe emphysema, indicating a strong foothold in advanced lung disease treatments which can be expanded through new product offerings or complementary therapies.

Strategic Industry Engagement Participation in prominent healthcare conferences such as Goldman Sachs and Bank of America Securities highlights opportunities to strengthen relationships with key healthcare stakeholders and explore partnerships or pilot programs with leading medical institutions.

Market Leadership & Funding With a substantial funding of 338 million dollars and a revenue range between 50 to 100 million, Pulmonx is well-positioned to scale sales efforts, invest in market expansion, and accelerate product adoption in both existing and new geographical markets.

Regulatory & Clinical Focus The company's emphasis on FDA-approved procedures and specific contraindications provides a targeted approach for clinical teams, enabling tailored sales strategies to educated providers and health systems interested in minimally invasive lung treatments.

Leadership Transition The recent change in leadership with the retirement of the CEO and appointment of a new CFO suggests opportunities to engage with corporate decision-makers and support strategic initiatives during this transition phase.

Similar companies to Pulmonx Corporation

Pulmonx Corporation Tech Stack

Pulmonx Corporation uses 8 technology products and services including TrackJS, HubSpot Analytics, StackAdapt, and more. Explore Pulmonx Corporation's tech stack below.

  • TrackJS
    Analytics
  • HubSpot Analytics
    Analytics
  • StackAdapt
    Demand Side Platforms
  • Google Cloud
    Infrastructure As A Service
  • JSON-LD
    Javascript Frameworks
  • jQuery Migrate
    Javascript Libraries
  • NIST Cybersecurity Framework
    Security
  • Animate.css
    UI Frameworks

Media & News

Pulmonx Corporation's Email Address Formats

Pulmonx Corporation uses at least 1 format(s):
Pulmonx Corporation Email FormatsExamplePercentage
FLast@pulmonx.comJDoe@pulmonx.com
98%
Last@pulmonx.comDoe@pulmonx.com
1%
FMLast@pulmonx.comJMDoe@pulmonx.com
1%

Frequently Asked Questions

Where is Pulmonx Corporation's headquarters located?

Minus sign iconPlus sign icon
Pulmonx Corporation's main headquarters is located at 700 Chesapeake Drive Redwood City, California 94063 United States. The company has employees across 4 continents, including North AmericaEuropeOceania.

What is Pulmonx Corporation's phone number?

Minus sign iconPlus sign icon
You can contact Pulmonx Corporation's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Pulmonx Corporation's official website and social media links?

Minus sign iconPlus sign icon
Pulmonx Corporation's official website is pulmonx.com and has social profiles on LinkedInCrunchbase.

What is Pulmonx Corporation's NAICS code?

Minus sign iconPlus sign icon
Pulmonx Corporation's NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does Pulmonx Corporation have currently?

Minus sign iconPlus sign icon
As of June 2026, Pulmonx Corporation has approximately 274 employees across 4 continents, including North AmericaEuropeOceania. Key team members include Chief Operating Officer & Chief Financial Officer: D. S.Vice President Of Clinical Affairs: R. M.Vp Sales: P. S.. Explore Pulmonx Corporation's employee directory with LeadIQ.

What industry does Pulmonx Corporation belong to?

Minus sign iconPlus sign icon
Pulmonx Corporation operates in the Medical Equipment Manufacturing industry.

What technology does Pulmonx Corporation use?

Minus sign iconPlus sign icon
Pulmonx Corporation's tech stack includes TrackJSHubSpot AnalyticsStackAdaptGoogle CloudJSON-LDjQuery MigrateNIST Cybersecurity FrameworkAnimate.css.

What is Pulmonx Corporation's email format?

Minus sign iconPlus sign icon
Pulmonx Corporation's email format typically follows the pattern of FLast@pulmonx.com. Find more Pulmonx Corporation email formats with LeadIQ.

Pulmonx Corporation

Medical Equipment ManufacturingCalifornia, United States201-500 Employees

Pulmonx has developed the Zephyr Endobronchial Valve, a minimally invasive treatment for COPD/emphysema. The one-time procedure is done by bronchoscopy and requires no cutting or incisions. During the procedure, on average 4 tiny valves are placed in the airways to block off the diseased parts of the lung which allows trapped air to escape until the lobe is reduced. Reducing hyperinflation allows the healthier parts of the lungs to expand and take in more air. This results in patients being able to breathe easier and have less shortness of breath.1 

Complications of the Zephyr Endobronchial Valve treatment can include but are not limited to pneumothorax, worsening of COPD symptoms, hemoptysis, pneumonia, dyspnea and, in rare cases, death.1

1. Criner G et al AM J Resp Crit Care Med 2018, Published on 22-May-2018 as 10.1164/rccm.201803-0590OC

Brief Statement: The Pulmonx Zephyr® Endobronchial Valves are implantable bronchial valves indicated for the bronchoscopic treatment of adult patients with hyperinflation associated with severe emphysema in regions of the lung that have little to no collateral ventilation. The Zephyr Valve is contraindicated for: Patients for whom bronchoscopic procedures are contraindicated; those with evidence of active pulmonary infection; known allergies to Nitinol (nickel-titanium) or its constituent metals (nickel or titanium); known allergies to silicone, or with large bullae encompassing greater than 30% of either lung; Patients who have not quit smoking. The Zephyr Valve should be used with caution and only after careful consideration in treating patients with: Prior lung transplant, LVRS, median sternotomy, or lobectomy; Congestive heart failure or recent myocardial infarction; FEV1 <15% of predicted value. Use is restricted to a trained physician. Prior to use, please reference the Zephyr Endobronchial Valve System Instructions for more information on indications, contraindications, warnings, all precautions, and adverse events.

Section iconCompany Overview

Headquarters
700 Chesapeake Drive Redwood City, California 94063 United States
Phone number
NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Employees
201-500

Section iconFunding & Financials

  • $50M$100M

    Pulmonx Corporation's revenue is estimated to be in the range of $50M$100M

Section iconFunding & Financials

  • $50M$100M

    Pulmonx Corporation's revenue is estimated to be in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.